Gapping up
In reaction to earnings/guidance:
- TGI +9.5%, KEYS +8.4%, DT +8.1%, WIX +8%, AEG +6.3% (Trading update), NXGN +3.3%, RSKD +2.2%, LPG +2%
Other news:
- WAL +9.9% (QTD deposit growth of $2.0 bln)
- RNA +9.6% (FDA has eased the partial clinical hold on AOC 1001)
- PTCT +5.4% (APHENITY trial achieved primary endpoint)
- ICPT +3.6% (receives FDA Orphan drug designation)
- PUMP +3.4% (announces $100 mln share repurchase program)
- NYCB +3.1% (prices secondary offering of 39,032,006 shares of common stock by the FDIC)
- PDLB +2.8% (repurchase program)
- MPLN +2.6% (stock offering)
- TOST +2.2% (Director disclosed the purchase of 635,000 shares worth more than $12.5 mln)
- TSLA +1.5% (hosted shareholder meeting outlining multiple developments)
- NOW +1.4% (repurchase program)
- LYFT +1.1% (appoints new CFO)
Analyst comments:
- APG +5% (upgraded to Outperform from Neutral at Robert Baird)
- APP +4.9% (upgraded to Buy from Neutral at BofA Securities)
- FLNC +3.7% (upgraded to Neutral from Underperform at BofA Securities)
- WYNN +2.9% (upgraded to Overweight from Equal Weight at Barclays)
- ABNB +1% (upgraded to Buy from Accumulate at Phillip Securities)